138 related articles for article (PubMed ID: 1641255)
1. Concurrent zidovudine-induced myopathy and hepatoxicity in patients treated for human immunodeficiency virus (HIV) infection.
Chen SC; Barker SM; Mitchell DH; Stevens SM; O'Neill P; Cunningham AL
Pathology; 1992 Apr; 24(2):109-11. PubMed ID: 1641255
[TBL] [Abstract][Full Text] [Related]
2. Ultrastructural characteristics and DNA immunocytochemistry in human immunodeficiency virus and zidovudine-associated myopathies.
Pezeshkpour G; Illa I; Dalakas MC
Hum Pathol; 1991 Dec; 22(12):1281-8. PubMed ID: 1748434
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial myopathy caused by long-term zidovudine therapy.
Dalakas MC; Illa I; Pezeshkpour GH; Laukaitis JP; Cohen B; Griffin JL
N Engl J Med; 1990 Apr; 322(16):1098-105. PubMed ID: 2320079
[TBL] [Abstract][Full Text] [Related]
4. Skeletal muscle involvement in HIV-infected patients.
Gherardi RK
Neuropathol Appl Neurobiol; 1994 Jun; 20(3):232-7. PubMed ID: 7936072
[TBL] [Abstract][Full Text] [Related]
5. Myopathy in HIV infection: the role of zidovudine and the significance of tubuloreticular inclusions.
Lane RJ; McLean KA; Moss J; Woodrow DF
Neuropathol Appl Neurobiol; 1993 Oct; 19(5):406-13. PubMed ID: 8278024
[TBL] [Abstract][Full Text] [Related]
6. Zidovudine therapy and myopathies associated with human immunodeficiency virus infection.
Chariot P; Ruet E; Gherardi R
Ann Neurol; 1994 Feb; 35(2):247-8. PubMed ID: 8109910
[No Abstract] [Full Text] [Related]
7. Zidovudine myopathy: a distinctive disorder associated with mitochondrial dysfunction.
Mhiri C; Baudrimont M; Bonne G; Geny C; Degoul F; Marsac C; Roullet E; Gherardi R
Ann Neurol; 1991 Jun; 29(6):606-14. PubMed ID: 1892364
[TBL] [Abstract][Full Text] [Related]
8. [Muscular complications in HIV infection].
Authier FJ; Chariot P; Gherardi R
Arch Anat Cytol Pathol; 1997; 45(2-3):174-8. PubMed ID: 9382610
[TBL] [Abstract][Full Text] [Related]
9. Myopathies associated with human immunodeficiency virus and zidovudine: can their effects be distinguished?
Simpson DM; Citak KA; Godfrey E; Godbold J; Wolfe DE
Neurology; 1993 May; 43(5):971-6. PubMed ID: 8492955
[TBL] [Abstract][Full Text] [Related]
10. HIV or zidovudine myopathy?
Gherardi R; Chariot P
Neurology; 1994 Feb; 44(2):361-2; author reply 362-4. PubMed ID: 8309597
[No Abstract] [Full Text] [Related]
11. HIV or zidovudine myopathy?
Dalakas M
Neurology; 1994 Feb; 44(2):360-1; author reply 362-4. PubMed ID: 8309594
[No Abstract] [Full Text] [Related]
12. Human immunodeficiency virus type 1 infection and myopathy: clinical relevance of zidovudine therapy.
Grau JM; Masanés F; Pedrol E; Casademont J; Fernández-Solá J; Urbano-Márquez A
Ann Neurol; 1993 Aug; 34(2):206-11. PubMed ID: 8338345
[TBL] [Abstract][Full Text] [Related]
13. Myopathy with human immunodeficiency virus type 1 (HIV-1) infection: HIV-1 or zidovudine?
Till M; MacDonell KB
Ann Intern Med; 1990 Oct; 113(7):492-4. PubMed ID: 1975486
[No Abstract] [Full Text] [Related]
14. Characteristics and pathogenesis of myositis in human immunodeficiency virus infection--distinction from azidothymidine-induced myopathy.
Espinoza LR; Aguilar JL; Espinoza CG; Gresh J; Jara J; Silveira LH; Martinez-Osuna P; Seleznick M
Rheum Dis Clin North Am; 1991 Feb; 17(1):117-29. PubMed ID: 2041882
[TBL] [Abstract][Full Text] [Related]
15. [Muscular involvement in HIV infection].
Gherardi R; Chariot P; Authier FJ
Rev Neurol (Paris); 1995 Nov; 151(11):603-7. PubMed ID: 8745623
[TBL] [Abstract][Full Text] [Related]
16. [Lactic acidosis and hepatic mitochondrial changes during a treatment with zidovudine].
Charton-Bain MC; Flamant M; Aubertin JM; Belair MF; Gilquin J; Kazatchkine M; Bruneval P
Gastroenterol Clin Biol; 1997; 21(12):979-81. PubMed ID: 9587562
[TBL] [Abstract][Full Text] [Related]
17. Zidovudine intolerance.
Groopman JE
Rev Infect Dis; 1990; 12 Suppl 5():S500-6. PubMed ID: 2201071
[TBL] [Abstract][Full Text] [Related]
18. Nuclear and mitochondrial changes of muscle fibers in AIDS after treatment with high doses of zidovudine.
Schröder JM; Bertram M; Schnabel R; Pfaff U
Acta Neuropathol; 1992; 85(1):39-47. PubMed ID: 1285495
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of zidovudine-induced mitochondrial toxicity and myopathy.
Scruggs ER; Dirks Naylor AJ
Pharmacology; 2008; 82(2):83-8. PubMed ID: 18504416
[TBL] [Abstract][Full Text] [Related]
20. [Toxic drug-induced proximal myopathy in CDC C3 HIV-infection].
Weisser M
Praxis (Bern 1994); 1997 Oct; 86(43):1708-10. PubMed ID: 9432697
[No Abstract] [Full Text] [Related]
[Next] [New Search]
